Quantum Biopharma (QNTM) Competitors

Quantum Biopharma (NASDAQ:QNTM) and Vor Biopharma (NYSE:VOR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

Is QNTM or VOR more profitable?

Vor Biopharma's return on equity of 0.00% beat Quantum Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum Biopharma	N/A	-270.22%	-131.87%
Vor Biopharma	N/A	N/A	N/A

Which has stronger valuation and earnings, QNTM or VOR?

Quantum Biopharma is trading at a lower price-to-earnings ratio than Vor Biopharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum Biopharma	N/A	N/A	-$14.20M	-$14.02	-1.17
Vor Biopharma	N/A	N/A	N/A	-$13.66	-0.15

Which has more volatility and risk, QNTM or VOR?

Quantum Biopharma has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Comparatively, Vor Biopharma has a beta of 2.06, meaning that its share price is 106% more volatile than the S&P 500.

Do analysts rate QNTM or VOR?

Vor Biopharma has a consensus target price of $6.07, indicating a potential upside of 191.67%. Given Vor Biopharma's stronger consensus rating and higher probable upside, analysts plainly believe Vor Biopharma is more favorable than Quantum Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum Biopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Vor Biopharma	0 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.56

Does the media refer more to QNTM or VOR?

In the previous week, Vor Biopharma had 1 more articles in the media than Quantum Biopharma. MarketBeat recorded 3 mentions for Vor Biopharma and 2 mentions for Quantum Biopharma. Quantum Biopharma's average media sentiment score of 0.00 beat Vor Biopharma's score of -0.02 indicating that Quantum Biopharma is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum Biopharma	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Vor Biopharma	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders and institutionals believe in QNTM or VOR?

1.2% of Quantum Biopharma shares are held by institutional investors. Comparatively, 97.3% of Vor Biopharma shares are held by institutional investors. 8.5% of Quantum Biopharma shares are held by company insiders. Comparatively, 0.5% of Vor Biopharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Vor Biopharma beats Quantum Biopharma on 9 of the 12 factors compared between the two stocks.